• Pieris Pharmaceuticals to Present Phase 1 Data for 4-1BB/HER2 Bispecific PRS-343 at the Society for Immunotherapy of Cancer (SITC)... ACCESS Newswire Mon, 28 Apr 2025 23:47:02 GMT
• (pvla) technical pivots with risk controls news.stocktradersdaily.com Wed, 23 Apr 2025 04:34:00 GMT
• ebenbuild contributes cutting-edge digital lung simulations to pulmonary fibrosis drug development The Manila Times Wed, 09 Apr 2025 07:00:00 GMT
• pieris pharmaceuticals to host third quarter 2021 investor call and provide corporate update on november 2, 2021 ACCESS Newswire Thu, 03 Apr 2025 11:58:49 GMT
• palvella therapeutics reports 2024 financial results and advances rare disease pipeline MyChesCo Wed, 02 Apr 2025 07:00:00 GMT
• asgard therapeutics appoints immunology expert shane olwill as chief development officer Yahoo Wed, 26 Mar 2025 08:30:00 GMT
• pieris pharmaceuticals stock soars to 52-week high of $29.01 Investing.com Wed, 12 Mar 2025 07:00:00 GMT
• pieris pharmaceuticals stock hits 52-week high at $22.56 by investing.com Investing.com Canada Thu, 06 Mar 2025 02:54:08 GMT
• pieris pharmaceuticals stock hits 52-week high at $22.56 Investing.com Wed, 05 Mar 2025 08:00:00 GMT
• pieris pharmaceuticals to host full-year 2019 investor call and corporate update on march 12, 2020 ACCESS Newswire Sat, 01 Mar 2025 23:02:45 GMT
• pieris pharmaceuticals to present at the 2019 h.c. wainwright global life sciences conference ACCESS Newswire Fri, 28 Feb 2025 08:57:31 GMT
• palvella therapeutics and pieris pharmaceuticals finalize merger to focus on rare disease treatments MSN Fri, 28 Feb 2025 07:53:28 GMT
• pieris pharmaceuticals to host third quarter 2020 investor call and corporate update on november 4, 2020 ACCESS Newswire Thu, 27 Feb 2025 23:19:39 GMT
• pieris pharmaceuticals to host full-year 2020 investor call and provide corporate update on march 30, 2021 ACCESS Newswire Thu, 27 Feb 2025 18:22:14 GMT
• pieris pharmaceuticals reports third quarter 2022 financial results and provides corporate update ACCESS Newswire Fri, 21 Feb 2025 09:02:28 GMT
• Palvella Therapeutics closes on Pieris merger; completes nearly $80M private placement Pennsylvania Business Report - Sun, 16 Feb 2025 16:18:15 GMT
• four new option listings and one option delisting on january 29th TipRanks Wed, 29 Jan 2025 13:38:07 GMT
• pieris pharmaceuticals announces milestone achievement for boston pharmaceuticals' initiation of phase 1/2 study of bos-342, a 4-1... ACCESS Newswire Mon, 27 Jan 2025 03:20:53 GMT
• pieris pharmaceuticals announces strategy to maximize partnered milestone and royalty potential ACCESS Newswire Fri, 24 Jan 2025 22:20:16 GMT
• pieris pharmaceuticals announces prs-220 presentation at ers highlighting preclinical data for ctgf inhibitor ACCESS Newswire Fri, 24 Jan 2025 20:58:24 GMT
• pirs stock earnings: pieris pharmaceuticals reported results for q1 2024 MSN Sun, 19 Jan 2025 18:50:50 GMT
• palvella reports positive phase 2 study on qtorin rapamycin for rare skin disease by investing.com Investing.com South Africa Fri, 10 Jan 2025 08:00:00 GMT
• stocknews.com begins coverage on pieris pharmaceuticals (nasdaq:pirs) Defense World Fri, 10 Jan 2025 08:00:00 GMT
• palvella therapeutics and pieris pharmaceuticals finalize merger to focus on rare disease treatments MSN Mon, 06 Jan 2025 03:07:17 GMT
• immedica pharma to acquire marinus pharmaceuticals in $151 million deal MyChesCo Sat, 04 Jan 2025 13:00:00 GMT
• galera therapeutics acquires nova pharmaceuticals to advance breast cancer treatment MyChesCo Thu, 02 Jan 2025 09:00:00 GMT
• pieris pharmaceuticals (nasdaq:pirs) now covered by analysts at stocknews.com Defense World Thu, 02 Jan 2025 08:00:00 GMT
• palvella therapeutics stock gains attention with phase 3 trial data expected in early 2026 Investing.com Thu, 26 Dec 2024 08:00:00 GMT
• pieris pharmaceuticals (nasdaq:pirs) coverage initiated at stocknews.com Defense World Wed, 25 Dec 2024 07:08:16 GMT
• wayne’s palvella therapeutics completes reverse merger with pieris pharmaceutical MSN Sat, 21 Dec 2024 06:06:56 GMT
• Wayne’s Palvella Therapeutics Completes Reverse Merger with Pieris Pharmaceutical VISTA.Today Fri, 20 Dec 2024 08:00:00 GMT
• verrica pharmaceuticals reports progress on molluscum treatment and pipeline development MyChesCo Fri, 20 Dec 2024 08:00:00 GMT
• wayne’s palvella therapeutics completes reverse merger with pieris pharmaceutical VISTA.Today Thu, 19 Dec 2024 16:14:53 GMT
• pieris pharmaceuticals, inc. announces unaudited consolidated earnings results for the first quarter ended march 31, 2021 Marketscreener.com Thu, 19 Dec 2024 08:27:11 GMT
• pieris pharmaceuticals and boston pharmaceuticals enter into an exclusive worldwide product license for prs-342, a 4-1bb/gpc3 immu... Marketscreener.com Thu, 19 Dec 2024 08:16:54 GMT
• palvella therapeutics director george jenkins acquires $51,720 in shares Investing.com Thu, 19 Dec 2024 08:00:00 GMT
• larimar therapeutics reports promising results for friedreich’s ataxia treatment MyChesCo Thu, 19 Dec 2024 06:00:00 GMT
• pieris pharmaceuticals, inc. reports earnings results for the third quarter and nine months ended september 30, 2021 Marketscreener.com Wed, 18 Dec 2024 14:00:32 GMT
• pieris pharmaceuticals, inc. announces management changes Marketscreener.com Tue, 17 Dec 2024 04:11:12 GMT
• pieris pharmaceuticals, inc. appoints julian adams to its board of directors Marketscreener.com Tue, 17 Dec 2024 03:48:25 GMT
• pieris pharmaceuticals, inc. appoints claude knopf as senior vice president and chief business officer Marketscreener.com Mon, 16 Dec 2024 20:50:34 GMT
• Main Line biotech firm completes reverse merger, raises $78.9 million The Business Journals Mon, 16 Dec 2024 08:00:00 GMT
• After losing AstraZeneca collab, Boston biotech opts for reverse merger The Business Journals Mon, 16 Dec 2024 08:00:00 GMT
• palvella therapeutics and pieris pharmaceuticals finalize merger to focus on rare disease treatments MSN Mon, 16 Dec 2024 08:00:00 GMT
• palvella therapeutics closes merger with pieris pharmaceuticals citybiz Mon, 16 Dec 2024 04:24:06 GMT
• pieris pharmaceuticals announces $5 million milestone from seagen for initiation of phase 1 trial of cd228 x 4-1bb bispecific mole... Marketscreener.com Sun, 15 Dec 2024 12:54:14 GMT
• Palvella Therapeutics Closes Merger with Pieris Pharmaceuticals citybiz Sun, 15 Dec 2024 08:00:00 GMT
• pieris pharmaceuticals investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates merger of p... Marketscreener.com Sun, 15 Dec 2024 03:38:57 GMT
• pieris pharmaceuticals, inc. reports earnings results for the third quarter and nine months ended september 30, 2024 Marketscreener.com Sun, 15 Dec 2024 03:02:31 GMT
• palvella therapeutics and pieris pharmaceuticals finalize merger to focus on rare disease treatments MyChesCo Sat, 14 Dec 2024 08:00:00 GMT
• Palvella Therapeutics Secures $79M Funding, Completes Merger with Strong Cash Position Through 2027 Stock Titan Fri, 13 Dec 2024 08:00:00 GMT
• palvella therapeutics announces nasdaq debut under ticker pvla following merger with pieris pharmaceuticals Nasdaq Fri, 13 Dec 2024 08:00:00 GMT
• palvella therapeutics announces closing of merger with pieris pharmaceuticals and concurrent private placement of $78.9 million Yahoo Finance Fri, 13 Dec 2024 08:00:00 GMT
• pvla - palvella therapeutics inc latest stock news & market updates StockTitan Fri, 13 Dec 2024 08:00:00 GMT
• palvella therapeutics closes on pieris merger; completes nearly $80m private placement Pennsylvania Business Report Fri, 13 Dec 2024 08:00:00 GMT
• pvla - palvella therapeutics, inc. latest stock news & market updates StockTitan Fri, 13 Dec 2024 08:00:00 GMT
• verrica pharmaceuticals grants stock option to new coo david zawitz MyChesCo Thu, 12 Dec 2024 18:00:00 GMT
• shareholder investigation: the m&a class action firm investigates the merger of pieris pharmaceuticals, inc. - pirs The Eastern Progress Online Wed, 11 Dec 2024 18:42:33 GMT
• ocugen to present at oppenheimer movers in rare disease summit MyChesCo Wed, 11 Dec 2024 08:00:00 GMT
• pieris pharmaceuticals, inc. appoints julian adams to its board of directors Marketscreener.com Mon, 09 Dec 2024 09:18:23 GMT
• shareholder investigation: halper sadeh llc investigates cyth, brkh, pirs, cfb on behalf of shareholders The Eastern Progress Online Sat, 07 Dec 2024 02:44:55 GMT
• pieris pharmaceuticals announces board changes and merger update Investing.com Wed, 04 Dec 2024 00:52:19 GMT
• nouscom appoints seasoned executive eckhard niemeier as chief business officer GlobeNewswire Tue, 03 Dec 2024 08:00:00 GMT
• pieris pharmaceuticals announces board changes and merger update Investing.com Tue, 03 Dec 2024 08:00:00 GMT
• virpax pharmaceuticals extends collaboration with nih center for pain management innovation MyChesCo Wed, 27 Nov 2024 08:00:00 GMT
• shareholder investigation: halper sadeh llc investigates pik, acnb, pirs, obde on behalf of shareholders The Malaysian Reserve Fri, 22 Nov 2024 08:00:00 GMT
• shareholder investigation: halper sadeh llc investigates cyth, brkh, pirs, cfb on behalf of shareholders The Bradford Era Thu, 21 Nov 2024 08:00:00 GMT
• pieris pharmaceuticals investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates merger of p... Business Wire Wed, 20 Nov 2024 08:00:00 GMT
• comparing evelo biosciences (nasdaq:evlo) and pieris pharmaceuticals (nasdaq:pirs) Defense World Mon, 18 Nov 2024 10:12:17 GMT
• greywolf appoints darlene deptula-hicks as chief financial officer BioSpace Thu, 14 Nov 2024 08:00:00 GMT
• lynx1 capital management lp adjusts stake in pieris pharmaceuticals inc GuruFocus.com Thu, 14 Nov 2024 08:00:00 GMT
• pieris pharmaceuticals (nasdaq:pirs) stock rating upgraded by stocknews.com Defense World Wed, 13 Nov 2024 08:02:46 GMT
• zentalis pharmaceuticals announces executive leadership GlobeNewswire Wed, 13 Nov 2024 08:00:00 GMT
• greywolf appoints darlene deptula-hicks as chief financial officer Business Wire Wed, 13 Nov 2024 08:00:00 GMT
• pieris pharmaceuticals: q3 earnings snapshot | national business news | voiceofalexandria.com Voice Of Alexandria Wed, 13 Nov 2024 08:00:00 GMT
• context therapeutics announces q3 2024 financial results and strategic advances MyChesCo Fri, 08 Nov 2024 08:00:00 GMT
• madrigal pharmaceuticals engages with investors at key conferences MyChesCo Fri, 08 Nov 2024 08:00:00 GMT
• palvella therapeutics announces first patient dosed in GlobeNewswire Thu, 07 Nov 2024 08:00:00 GMT
• sfa therapeutics strengthens patent portfolio for key drug candidates MyChesCo Mon, 28 Oct 2024 07:00:00 GMT
• pieris pharmaceuticals director buys series f preferred stock for $1 Investing.com Mon, 28 Oct 2024 07:00:00 GMT
• madrigal pharmaceuticals set to reveal q3 2024 financial results MyChesCo Fri, 18 Oct 2024 07:00:00 GMT
• palvella therapeutics appoints matthew e. korenberg as chief financial officer citybiz Thu, 17 Oct 2024 07:00:00 GMT
• palvella therapeutics announces presentations at the 12th GlobeNewswire Wed, 16 Oct 2024 03:17:15 GMT
• palvella therapeutics announces presentations at the 12th GlobeNewswire Tue, 15 Oct 2024 07:00:00 GMT
• uae hepcidin market with industry share, growth, trends analysis by (2024-2034) IndiaPolitics.com Fri, 11 Oct 2024 05:47:20 GMT
• aridis pharmaceuticals (otc:ards) stock quotes, forecast and news summary Benzinga Wed, 09 Oct 2024 07:00:00 GMT
• wayne-based palvella therapeutics poised to go public later this year MSN Wed, 09 Oct 2024 04:26:39 GMT
• palvella therapeutics awarded up to $2.6 million grant from the u.s. food and drug administration (fda) office of orphan products ... GlobeNewswire Thu, 03 Oct 2024 07:00:00 GMT
• hepcidin market generated opportunities, future scope (2024-2034) Talented India Mon, 30 Sep 2024 04:03:53 GMT
• pieris pharmaceuticals, inc. (nasdaq:pirs) sees significant decrease in short interest Defense World Fri, 27 Sep 2024 07:00:00 GMT
• New Alzheimer’s Therapy Shows Remarkable Results in Animal Trials SciTechDaily Wed, 25 Sep 2024 07:00:00 GMT
• asthma market is predicted to exhibit remarkable growth during openPR Mon, 23 Sep 2024 20:34:00 GMT
• how the (pirs) price action is used to our advantage Stock Traders Daily Sat, 14 Sep 2024 00:48:00 GMT
• anemia and other blood disorder drugs market size, share, growth, analysisand forecast 2024-2033 WhaTech Wed, 04 Sep 2024 07:00:00 GMT
• pirs stock alert: halper sadeh llc is investigating whether the merger of pieris pharmaceuticals, inc. is fair to shareholders Business Wire Tue, 03 Sep 2024 07:00:00 GMT
• palvella therapeutics and pieris pharmaceuticals announce definitive merger agreement substack.com Wed, 28 Aug 2024 07:00:00 GMT
• pirs stock earnings: pieris pharmaceuticals reported results for q2 2024 MSN Tue, 27 Aug 2024 18:22:32 GMT
• wayne-based palvella therapeutics poised to go public later this year MSN Sat, 24 Aug 2024 06:43:08 GMT
• wayne-based palvella therapeutics poised to go public later this year VISTA.Today Wed, 21 Aug 2024 15:27:16 GMT
• pieris pharmaceuticals second quarter 2024 earnings: us$2.76 loss per share (vs us$3.63 profit in 2q 2023) Yahoo Finance Mon, 19 Aug 2024 07:00:00 GMT
• we're a little worried about pieris pharmaceuticals' (nasdaq:pirs) cash burn rate Yahoo Finance Sat, 17 Aug 2024 07:00:00 GMT
• shareholder investigation: halper sadeh llc investigates afbi, env, pirs, baly on behalf of shareholders GlobeNewswire Sat, 17 Aug 2024 07:00:00 GMT
• shareholder investigation: halper sadeh llc investigates k and pirs on behalf of shareholders ForexTV.com Fri, 16 Aug 2024 12:36:28 GMT
• traws pharma reports q2 financials and merger with trawsfynydd therapeutics MyChesCo Fri, 16 Aug 2024 07:00:00 GMT
• shareholder investigation: the m&a class action firm investigates the merger of pieris pharmaceuticals, inc. - pirs PR Newswire Fri, 16 Aug 2024 07:00:00 GMT
• inside the deal: how palvella therapeutics plans to go public through a reverse merger with a boston pharma fi The Business Journals Fri, 16 Aug 2024 00:57:00 GMT
• pieris pharmaceuticals: q2 earnings snapshot San Antonio Express-News Thu, 15 Aug 2024 07:37:41 GMT
• Inside the deal: How Palvella Therapeutics plans to go public through a reverse merger with a Boston pharma firm The Business Journals Thu, 15 Aug 2024 07:00:00 GMT
• stockholder alert: the m&a class action firm investigates the mergers of pirs, env, gvp AccessWire Thu, 15 Aug 2024 07:00:00 GMT
• shareholder investigation: halper sadeh llc investigates k and pirs on behalf of shareholders Finansavisen Wed, 14 Aug 2024 07:00:00 GMT
• pieris pharmaceuticals, inc. reports earnings results for the second quarter and six months ended june 30, 2024 Marketscreener.com Wed, 14 Aug 2024 07:00:00 GMT
Pieris Pharmaceuticals, Inc(NASDAQ:PIRS) 
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs in the United States. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular...
Website: http://www.pieris.com
Founded: 2001
Full Time Employees: 114
Sector: Healthcare
Industry: Biotechnology